Mydecine Innovations Group Inc. announced the appointment of Dr. Victoria Hale to the company's Board of Directors. Dr. Hale is a pharmaceutical scientist and executive, as well as a global health social entrepreneur. She currently serves as Chair of the Board of the Multidisciplinary Association for Psychedelic Studies (MAPS).
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0091 USD | +20.32% | -35.92% | -38.93% |
05-01 | Mydecine Innovations Group Inc. announced that it expects to receive CAD 1 million in funding | CI |
02-23 | Mydecine Innovations Closes Partial Debt Settlement | MT |
1st Jan change | Capi. | |
---|---|---|
-38.93% | 467K | |
+52.03% | 55.7B | |
+41.08% | 39.91B | |
-5.93% | 39.57B | |
-5.56% | 28.16B | |
+16.09% | 26.3B | |
-19.81% | 18.94B | |
+32.39% | 12.17B | |
+26.55% | 12.12B | |
+1.50% | 12.12B |
- Stock Market
- Equities
- MYCOF Stock
- News Mydecine Innovations Group Inc.
- Mydecine Innovations Group Inc. Appoints Victoria Hale as Newest Independent Board Member